CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer

Anticancer Research

Volumn 19, Issue 4 A, 1999, Pages 2443-2450

  Griesenberg, D ^a   Nurnberg R ^a   Bahlo, M ^a   Klapdor, R ^a,b  

^a ZeTDT Ctr Clin Exp Tum M   (Germany)

^b ZeTDT GmbH   (Germany)

Author keywords

Colorectal cancer; FOBT; Follow up; Tumor markers

Indexed keywords

CA 19-9 ANTIGEN; CA 72-4 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; BARIUM ENEMA; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNORADIOMETRIC ASSAY; MALE; MIDDLE AGED; NEOPLASM STAGING; OCCULT BLOOD; PEPTIDES; PHYSICAL EXAMINATION; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0344069532     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Boeing H, Wahrendorf J: Epidemiologie kolorektaler Karzinome. Internist 32: 306-314, 1991.
2. Boring CC, Squires TS, Tong T: Cancer statistics. CA Cancer J Clin 43: 323-332, 1993.
3. Statistisches Bundesamt: Todesursachen in Deutschland. Metzler und Poeschel, 1995.
4. Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, Wickerham D, et al: Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 80: 21-29, 1988.
5. International multicentre pooled analysis of colon cancer trials (IMPACT) investigators: Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345: 939-944, 1995.
6. Krook J, Moertel C, Gunderson L, Wieand H, Collins R, Beart R, et al: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324: 709-715, 1991.
7. Laurie JA, Moertel CG, Fleming TR: Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. J Clin Oncol 7: 1447-1456, 1989.
8. Moertel CG: Chemotherapy for colorectal cancer. N Engl J Med 330: 1136-1142, 1994.
9. Winawer S, Fletcher R, Miller L, Godlee F, Stolar M, Mulrow C, Woolf S, Glick S, Ganiats T, Bond J, Rosen L, Zapka J, Olsen S, Giardiello F, Sisk J, van Antwerp R, Brown-Davis C, Marciniak D, Mayer R: Colorectal cancer screening : clinical guidelines and rationale. Gastroenterology 112: 594-642, 1997.
10. Levin B, Hess K, Johnson C: Screening for colorectal cancer. A comparison of 3 fecal occult blood tests. Arch Intern Med 157: 970-976, 1997.
11. Mandel J, Bond J, Church T, Snover D, Bradley M, Schuman L, Ederer F: Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 328: 1365-1371, 1993.
12. Hardcastle JD, Thomas WM, Chamberlain JO, Pye G, Sheffield J, James PD, et al: Randomised, controlled trial of faecal occult blood screening for colorectal cancer: results for first 107, 349 subjects. Lancet I: 1160-1164, 1989.
13. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O: Randomised study of screening for colorectal cancer with fecal-occult-blood test. Lancet 348: 1467-1471, 1996.
14. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS: A case-control study of screening sigmoidoscopy and mortality from colorectal carcinoma. N Engl j Med 526: 653-657, 1992.
15. Puchner R, Allinger S, Doblhofer F, Wallner M, Knoflach P: Komplikationen der diagnostischen und interventionellen Koloskopie. Wien Klin Wochenschr 108/5: 142-146, 1996.
16. Byrd RL, Boggs HW Jr, Slagle GW, Cole PA: Reliability of colonoscopy. Dis Colon Rectum 32: 1023-1025, 1989.
17. Jensen J, Kewenter J, Asztély M, Lycke G, Wojciechowski J: Double contrast barium enema and flexible rectosigmoidoscopy: a reliable diagnostic combination for detection of colorectal neoplasm. Br J Surg 77: 270-272, 1990.
18. Roberts PJ, Kuusela P, Carpelan-Holström M, Haglund C: Value of different tumor markers in colorectal cancer In: Tumor Associated Antigens, Oncogenes, Receptors, Cytokines in Tumor Diagnosis and Therapy at the Beginning of the Nineties (Klapdor R. ed.) München, Zuckschwerdt, 1992, pp 30-32.
19. Lorenz M, Weber T, Baum RP, Runge U, Hertel A, Hottenrott C: Clinical experience with CA 72-4 in comparison with CA 19-9 and CEA IRMAs in gastrointestinal tumors and benign diseases. In : Recent Results in Tumor Diagnosis and Therapy (Klapdor R. ed.) München, Zuckschwerdt, 1990, pp 54-68.
20. Jaulnaksne I, Donina S, Zakenfelds G, Januskevics V, Svarcbergs A: Comparison of the tumor markers CA 19-9 and CEA for follow-up of patients with gastrointestinal cancer. In: Current Tumor Diagnosis: Applications, Clinical Relevance, Research, Trends (Klapdor ed.) München, Zuckschwerdt, 1994, pp 77-79.
21. Lamerz R: Tumormarker, Prinzipien und Klinik. Dt Ärztebl 86, Heft 15: B771-777, 1989.
22. Carpelan-Holmström M, Haglund C, Kuusela P, Järvinen H, Roberts PJ: Preoperative Ca 242 and CEA serum levels in patients with colorectal cancer. In: Current Tumor Diagnosis: Applications, Clinical Relevance, Research, Trends (Klapdor ed.) München, Zuckschwerdt, 1994, pp 57-60.
23. Kornek G, Depisch D, Temsch EM, Scheithauer W: Comparative analysis of cancer-associated antigen CA-195, CA 19-9 and carcinoembryonic antigen in diagnosis, follow-up and monitoring of response to chemotherapy in patients with gastrointestinal cancer. J Cancer Res Clin Oncol 117: 493-496, 1991.
24. Böhm B, Schwenk W, Hucke HP, Stock W: Does methodic long-term follow-up affect survival after curative resection of colorectal carcinoma ? Dis Colon Rectum 36: 280-286, 1993.
25. Mentges B, Brückner R: Prognostische Kriterien und Risikogruppen beim kolorektalen Karzinom. WMW13: 317-322, 1988.
26. Moertel C, Fleming T, Macdonald J, Haller D, Laurie J, Tangen C: An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 270 8: 943-948, 1993.
27. Chu D, Erickson C, Russell P, Thompson C, Lang N, Broadwater R, Westbrook K: Prognostic significance of carcinoembryonic antigen in colorectal carcinoma. Arch Surg 126: 314-316, 1991.
28. Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Pahl H, Fateh-Moghadam A: Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma. Anticancer Research 17: 2935-2938, 1997.
29. Wang J, Tang R, Chiang J: Value of carcinoembryonic antigen in the management of colorctal cancer Dis Colon Rectum 37(3): 272-277, 1994.
30. Filella X, Molina R, Grau JJ et al: Prognostic value of CA 19-9 levels in colorectal cancer. Ann Surg 216: 55-59, 1992.
31. Kimmig JM, Strauch M, Hallen M: Negativer Haemoccult®-Test bei malignen und prämalignen Kolonläsionen - Validierung des Haemoccult®-Tests durch hohe Koloskopie. Endoscopy 21: 136-140, 1989.
32. Rosen M, Chan L, Beart RW, Vukasin P, Anthone G: Follow-up of colorectal cancer , a meta analysis. Dis Colon Rectum 41: 116-1126, 1998.
33. Bruinvels DJ, Stiggelbout A, Kievit J, van Houwelingen H, Habbema D, van de Velde C: Follow-up of patients with colorectal cancer. Ann Surg.
34. Himal H S: Anastomotic recurrence of carcinoma of the colon and rectum - The value of endoscopy and serum CEA levels. Amer surg 57-334-337, 1991.
35. Quentmeier A, Schlag P, Smok M, Herfarth C: Re-operation for recurrent colorectal cancer: the importance of early diagnosis for resectability and survival. Europ J Surg Oncol 16: 319-325, 1990.
36. McAfee M, Allen M, Trastek V, Ilstrup D, Deschamps C, Pairolero P: Colorectal lung metastases: results of surgical excision. Ann Thorac Surg 55: 780-786, 1992.
37. Jahn H, Joergensen O, Kronborg O, Fenger C: Can Hemoccult-II™ replace colonoscopy in surveillance after radical surgery for colorectal cancer and after polypectomy ? Dis Colon Rectum 35: 253-256, 1992.
38. Hall C, Griffin J, Dykes PW, Alexander Williams J, Keighley MRB: Haemoccult does not reduce the need for colonoscopy in surveillance after curative resection for colorectal cancer. Gut 34: 227-229, 1993.
39. Crowson MC, Jewkes AJ, Acheson N, Fielding J: Haemoccult testing as an indicator of recurrent colorectal cancer: a 5-year prospective study Europ J Surg Oncol 17: 281-284, 1991.
40. Hermanek P, Gall AP, Altendorf A: Lokalrezidive nach Rectum-carcinom - Entstehung, Diagnose, Prognose. Langenbecks Arch Chir 356: 289-298, 1982.
41. Galandiuk S, Wieand H, Moertel C, Cha S, Fitzgibbons R, Pemberton J, Wolff B: Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 174: 27-32, 1992.